BRIEF published on 05/19/2026 at 07:05, 1 month 28 days ago Innate Pharma at the Jefferies Global Healthcare Conference Immunotherapy Cancer Innate Pharma Therapeutic Antibodies Jefferies Conference
BRIEF published on 05/19/2026 at 07:05, 1 month 28 days ago Innate Pharma to Attend Jefferies Global Healthcare Conference Biotechnology Cancer Treatment Immunotherapy Innate Pharma Jefferies Conference
PRESS RELEASE published on 05/19/2026 at 07:00, 1 month 28 days ago Inside Information / Other news releases Innate Pharma to participate in Jefferies Global Healthcare Conference on June 2-4, 2026 in New York, United States. Developing immunotherapies for cancer patients Biotechnology Innate Pharma Jefferies Global Healthcare Conference Immunothérapies Cancer Patients
BRIEF published on 04/17/2026 at 21:05, 2 months 29 days ago Innate Pharma presents interim results from the MATISSE trial at the AACR congress Lung Cancer Innate Pharma AACR 2026 IPH5201 Phase 2 MATISSE
BRIEF published on 04/17/2026 at 21:05, 2 months 29 days ago Innate Pharma Reveals Promising Interim Results in MATISSE Phase 2 Study Clinical Trials Lung Cancer Innate Pharma MATISSE Phase 2 IPH5201
PRESS RELEASE published on 04/17/2026 at 21:00, 2 months 29 days ago Inside Information / Other news releases Innate Pharma to present interim results of IPH5201 in MATISSE Phase 2 study at AACR 2026. Study aims to enhance NSCLC treatment with anti-CD39 monoclonal antibody NSCLC Innate Pharma AACR 2026 MATISSE Phase 2 IPH5201
BRIEF published on 04/13/2026 at 07:05, 3 months 3 days ago Innate Pharma Updates Share and Voting Rights as of April 2026 Biotechnology Shares And Voting Rights Innate Pharma April 2026 Euronext Nasdaq
BRIEF published on 04/13/2026 at 07:05, 3 months 3 days ago Innate Pharma: Capital and Voting Rights Update Voting Rights Biotechnology Actions Immunotherapy Innate Pharma
PRESS RELEASE published on 04/13/2026 at 07:00, 3 months 3 days ago Inside Information / Other news releases Innate Pharma releases total shares and voting rights as of April 9, 2026, in compliance with French regulations. Learn about its innovative immunotherapies for cancer patients Voting Rights Shares French Regulations Innate Pharma Immunothérapies
PRESS RELEASE published on 04/13/2026 at 07:00, 3 months 3 days ago Inside Information / Other news releases Innate Pharma to hold its Annual General Meeting of shareholders on May 21, 2026 at 10:30 a.m. CEST in Marseille. Shareholders must register shares by May 14, 2026, 00:00 Paris time, to attend Annual General Meeting Shareholders Registration Innate Pharma Marseille
Published on 07/16/2026 at 16:21, 5 hours 32 minutes ago First Canadian Graphite Completes Phase I Exploration on Zone 13 Discovery and Expands Lands Package
Published on 07/16/2026 at 15:30, 6 hours 23 minutes ago Caldwell Announces Leadership Appointments for Industrial Practice and Caldwell Analytics
Published on 07/16/2026 at 15:30, 6 hours 23 minutes ago Resilient Energy Inc. Advances Commercial Rollout; Operations Enter Final Stage Ahead of Revenue Generation
Published on 07/16/2026 at 14:00, 7 hours 53 minutes ago Stream Hatchet Named a Data Provider for the 2026 Esports World Cup
Published on 07/16/2026 at 13:00, 8 hours 53 minutes ago High Tide Resources Provides Update from its Labrador West Iron Project
Published on 07/16/2026 at 21:16, 37 minutes ago Hertz Energy Advances Its Lake George Antimony-Tungsten Project and Summarizes Lithium Project
Published on 07/16/2026 at 20:59, 54 minutes ago EQS-Adhoc: SMA publishes preliminary results for the second quarter of 2026 and raises full-year 2026 guidance
Published on 07/16/2026 at 20:39, 1 hour 13 minutes ago AUTODOC successfully optimises capital structure
Published on 07/16/2026 at 20:05, 1 hour 47 minutes ago Turkiye Garanti Bankasi A.S.: Announcement regarding Moody's rating affirmation
Published on 07/16/2026 at 19:10, 2 hours 43 minutes ago Monotype Introduces Enterprise Connector Beta, Exploring How Brand Governance Works Inside AI-Native Workflows
Published on 07/16/2026 at 18:08, 3 hours 45 minutes ago Aéroports de Paris S.A - June and half-year 2026 traffic figures
Published on 07/16/2026 at 08:45, 13 hours 8 minutes ago Air Liquide invests over 160M USD in the U.S. to supply advanced chips manufacturing in Arizona
Published on 07/15/2026 at 17:45, 1 day 4 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2026
